SILVER SPRING, Md., March 8, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialist, LLC ("HDS") are pleased to announce that they have entered into the final stages of negotiations to engage a well-known sports celebrity to act as Clotamin® national spokesperson. Clotamin is the world's first specialized OTC multivitamin product designed exclusively for use by patients on Warfarin® and other anticoagulants (blood thinners).
The proposed sports celebrity spokesperson is a current National Basketball Association (NBA) head coach and Naismith Basketball Hall of Fame nominated player. During his 15+ year career as a player in the NBA, he collected more than 10,000 points and 10,000 rebounds, won three championship rings, and was twice named to the NBA All-Star team. He is listed in the NBA Top 20 List for career games played, career rebounding leaders, and career playoff rebounding leaders. Since his retirement from active play, he has spent time as a popular NBA television commentator and as head coach with several NBA teams.
"We couldn't be happier about identifying a current Clotamin user who also happens to be a legendary player and coach in the NBA. We believe that a strong marketing campaign featuring this individual could really help to boost Clotamin awareness and sales across the board," stated Mackie A. Barch, CEO of Sunpeaks. "Upon successful conclusion of negotiations, we intend to launch a national ad campaign featuring the famous player/coach designed to drive Clotamin into new markets and distribution channels."
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
Contact: Financial Insights 888-248-8491 or [email protected]
SOURCE Sunpeaks Ventures, Inc.